HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 20 of 118
 next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleOba-Yamamoto, Chiho; Takeuchi, Jun; Nakamura, Akinobu; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Y.; Atsumi, Tatsuya; Miyoshi, HideakiImpact of low-starch high-fiber pasta on postprandial blood glucose-Nutrition, Metabolism and Cardiovascular Diseases-Feb-2022
articleKamoshima, Hikaru; Nomoto, Hiroshi; Yamashita, Kumiko; Takahashi, Yuka; Tsuchida, Kazuhisa; Kuwabara, Saki; Miya, Aika; Cho, Kyu Yong; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Ono, Yuri; Miyoshi, HideakiDo the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?-Endocrine journal-28-Jan-2022
articleWatanabe-Kusunoki, Kanako; Nakazawa, Daigo; Yamamoto, Junya; Matsuoka, Naoko; Kaneshima, Nobuharu; Nakagaki, Tasuku; Yamamoto, Rie; Maoka, Tomochika; Iwasaki, Sari; Tsuji, Takahiro; Fukasawa, Yuichiro; Nishimoto, Naoki; Nishio, Saori; Atsumi, TatsuyaComparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy-Medicine-2022
articleOe, Yuki; Kameda, Hiraku; Nomoto, Hiroshi; Sakamoto, Keita; Soyama, Takeshi; Cho, Kyu Yong; Nakamura, Akinobu; Iwasaki, Koji; Abo, Daisuke; Kudo, Kohsuke; Miyoshi, Hideaki; Atsumi, TatsuyaFavorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor A case report-Medicine-19-Nov-2021
articleHashimoto-Kameda, Reina; Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Omori, Kazuno; Nagai, So; Edagawa, Sachiko; Kawata, Shinichiro; Takeuchi, Jun; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiLowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)-Diabetes research and clinical practice-Oct-2021
articleMiya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, HideakiImpact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin-Journal of Diabetes Investigation-10-Aug-2021
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, HideakiImproved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study-Journal of Diabetes Investigation-10-Aug-2021
articleOba-Yamamoto, Chiho; Kameda, Hiraku; Miyoshi, Hideaki; Sekizaki, Tomonori; Takase, Takahiro; Yanagimachi, Tsuyoshi; Fujita, Yukihiro; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Nagai, So; Atsumi, TatsuyaAcromegaly Cases Exhibiting Increased Growth Hormone Levels during Oral Glucose Loading with Preadministration of Dipeptidyl Peptidase-4 Inhibitor-Internal medicine-1-Aug-2021
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone-Journal of Diabetes Investigation-8-Jul-2021
articleMiyoshi, Arina; Kameda, Hiraku; Nagai, So; Nakamura, Akinobu; Miya, Aika; Takase, Takahiro; Atsumi, Tatsuya; Miyoshi, HideakiBeneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis-Journal of Diabetes Investigation-8-Jul-2021
articleMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, TatsuyaImpaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment-Journal of diabetes investigation-May-2021
articleOba‐Yamamoto, Chiho; Takeuchi, Jun; Nakamura, Akinobu; Takikawa, Ryoko; Ozaki, Ayano; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, HideakiCombination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia-Journal of Diabetes Investigation-Apr-2021
articleNomoto, Hiroshi; Oba-Yamamoto, Chiho; Takahashi, Yuka; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, HideakiEffects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes : Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)-Diabetes Therapy-Mar-2021
article (author version)Ogata, Yusuke; Fujieda, Yuichiro; Sugawara, Masanari; Sato, Taiki; Ohnishi, Naoki; Kono, Michihito; Kato, Masaru; Oku, Kenji; Amengual, Olga; Atsumi, TatsuyaMorbidity and mortality in antiphospholipid syndrome based on cluster Analysis : a 10-year longitudinal cohort study-Rheumatology-Mar-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of diabetes investigation-Feb-2021
articleYuno, Akiko; Kenmotsu, Yoshiyuki; Takahashi, Yuka; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu ‍Yong; Nakamura, Akinobu; Yamashita, Yu; Nakamura, Junichi; Nakakubo, Sho; Kamada, Keisuke; Suzuki, Masaru; Sugino, Hirokazu; Inoshita, Naoko; Konno, Satoshi; Miyoshi, Hideaki; Atsumi, Tatsuya; Sawamura, Yutaka; Shimatsu, AkiraSuccessful management of a patient with active Cushing‍’‍s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia-Endocrine Journal-Feb-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of Diabetes Investigation-Feb-2021
articleNakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, TatsuyaInverse correlation between serum high‐molecular‐weight adiponectin and proinsulin level in a Japanese population : the DOSANCO Health Study-Journal of Diabetes Investigation-Jan-2021
articleBaba, Natsuki; Kameda, Hiraku; Nakamura, Akinobu; Yong Cho, Kyu; Nomoto, Hiroshi; Mitsuhashi, Tomoko; Miyoshi, Hideaki; Atsumi, TatsuyaSilent pituitary adenoma and metabolic disorders : obesity, abnormal glucose tolerance, hypertension and dyslipidemia-Endocrine Journal-2021
article (author version)Yanagiya, Shingo; Nakamura, Koshi; Ukawa, Shigekazu; Tsutsumi, Akizumi; Atsumi, Tatsuya; Tamakoshi, AkikoHousehold income and the risk of incident hypertension in employees at multiple workplaces in Japan : J-HOPE-Hypertension Research-Dec-2020
Showing results 1 to 20 of 118
 next >

 

Hokkaido University